About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 418 record(s)
Req # A-2021-001965
All documents submitted by BioNTech Manufacturing Company GmbH or Pfizer as part of the regulatory review that resulted in the Regulatory Decision Summary dated September 16, 2021 for the Comirnaty Vaccine. The full regulatory review decision from which the summary was generated. See https://covid-vaccine.canada.ca/comirnaty/productdetails.Organization: Health Canada
December 2023
Req # A-2021-002036
All documents in possession of the Executive Director level or higher related to potential violations of the Canada Health Act related to virtual health care and for-profit clinics from January 1, 2021 - January 31, 2022.Organization: Health Canada
December 2023
Req # A-2022-000151
All records related to Samsung Electronics Co. Ltd.’s Blood Pressure App. Medical Device Licence No. 107202 - issued December 22, 2021.Organization: Health Canada
December 2023
Req # A-2022-000822
All communications with representatives of Facebook regarding the potential or actual removal of content by Facebook described as “misinformation”, “disinformation”, “harmful”, "false", "conspiracy", "anti-vax", "anti-vaccination", "election denying", since January 1, 2018.Organization: Health Canada
December 2023
Req # A-2022-000997
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-10-20 for the medicinal ingredient rufinamide. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for rufinamide which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-10-20Organization: Health Canada
December 2023
Req # A-2022-001224
All emails to and from Minister of Health Jean-Yves Duclos relating to the following topics: COVID-19 vaccine safety and/or risks. COVID-19 vaccine efficacy or inefficacy. COVID-19 vaccine uptake. COVID-19 vaccine hesitancy. Any of the following drugs/supplements: Ivermectin, Hydroxychloroquine, N-Acetyl Cysteine (NAC), Quercetin, Zinc, Vitamin D, Nattokinase. Dates: 26 October 2021 - 16 December 2022.Organization: Health Canada
December 2023
Req # A-2022-001421
Meeting summary of the Inter-Departmental Deputy Minister‘s Task Force on the Opioid Overdose Crisis most recent meeting, prepared by the task force secretariat.Organization: Health Canada
December 2023
Req # A-2022-001489
Regarding an agreement in principle for a shared plan that will invest $4.81 billion in federal funding over 10 years in Nova Scotia. All documents related and/or regarding the following queries: Specify the shared health care priorities between Canada and Nova Scotia..Organization: Health Canada
December 2023
Req # A-2022-001503
All records related to the acquisition of Beleave Kannabis Corp. and its associated entities and licences by Wayne Patrick Consumer Products Ltd. also known as WPCP Ltd..Organization: Health Canada
December 2023
Req # A-2022-001547
Regarding an agreement in principle for a shared plan that will invest $4.81 billion in federal funding over 10 years in Nova Scotia. All documents related and/or regarding the following queries: The plan laid out on February 7, 2023, which Canada and Nova Scotia have agreed to in principle.Organization: Health Canada
December 2023